Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil for surrogate markers of atherosclerosis in female SLE patients
2005-001688-74Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in systemic lupus erythematosus (SLE) and atherosclerosis comparing Mycophenolate mofetil with Placebo (2 arms). Primary endpoint: Endothelial function via flow-mediated dilation. Started Aug 2005; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
systemic lupus erythematosus (SLE)atherosclerosis
Beyond the preview
Go deeper on 2005-001688-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001688-74.